# Nifedipine Plus Magnesium Sulfate Versus Magnesium Sulfate for Very Early Preterm Tocolysifs

> **NCT05345132** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 264 (estimated)

## Conditions studied

- Threatened Preterm Labor

## Interventions

- **DRUG:** Nifedipine 20 Mg
- **DRUG:** Magnesium sulfate

## Key facts

- **NCT ID:** NCT05345132
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-10
- **Primary completion:** 2025-11-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 264 (ESTIMATED)
- **Last updated:** 2023-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05345132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05345132, "Nifedipine Plus Magnesium Sulfate Versus Magnesium Sulfate for Very Early Preterm Tocolysifs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05345132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*